Apogee Therapeutics, Inc. Annual Net Cash Provided by (Used in) Investing Activities in USD for 2023

Taxonomy & unit: us-gaap: USD
Description: Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Summary: Apogee Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate for 2023.
Apogee Therapeutics, Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending March 31, 2024 was -$51.7M.

Net Cash Provided by (Used in) Investing Activities, Annual (USD)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
2023	-$274M			Jan 1, 2023	Dec 31, 2023	10-K	2024-03-05

* An asterisk sign (*) next to the value indicates that the value is likely invalid.